clinical trials

Researching Medical Marijuana May Soon Get Easier

Aug 27, 2019

Researchers hoping to study marijuana for scientific and medical purposes are one step closer to expanding their limited supply of the plant.

This week, the federal government announced it would begin processing dozens of pending applications for permission to cultivate the plant for scientific research.

The first drug to treat an aggressive form of multiple sclerosis has hit the market. 


Carol Gentry / WUSF Public Media

When you’ve been diagnosed with an incurable disease, there’s a huge incentive to sign up for a drug trial. But what if you’re healthy? What’s the incentive?

That’s the challenge facing researchers in a groundbreaking double-blind trial of an experimental drug meant to ward off Alzheimer’s disease. It is the Anti-Amyloid Treatment and Asymptomatic Alzheimer’s Disease trial, better known as “A4.”

Edna Perez’s perspective on sickle cell anemia is unusual. She’s Hispanic, not black; at 53, she has lived longer than most with the disease; and she’s also a registered nurse, so she is both caregiver and patient.

Perez is a participant in one of two clinical trials under way at the University of South Florida Health Clinics, according to the Tampa Bay Times.